108 related articles for article (PubMed ID: 11520413)
1. Preparation and properties of an alpha-1-protease inhibitor concentrate with high specific activity.
Mattes E; Matthiessen HP; Turecek PL; Schwarz HP
Vox Sang; 2001 Jul; 81(1):29-36. PubMed ID: 11520413
[TBL] [Abstract][Full Text] [Related]
2. Purification of alpha-1-proteinase inhibitor. Preparation and properties of a therapeutic concentrate.
Coan MH
Am J Med; 1988 Jun; 84(6A):32-6. PubMed ID: 3260071
[TBL] [Abstract][Full Text] [Related]
3. Biochemical, molecular characterization, and glycoproteomic analyses of alpha(1)-proteinase inhibitor products used for replacement therapy.
Kolarich D; Turecek PL; Weber A; Mitterer A; Graninger M; Matthiessen P; Nicolaes GA; Altmann F; Schwarz HP
Transfusion; 2006 Nov; 46(11):1959-77. PubMed ID: 17076852
[TBL] [Abstract][Full Text] [Related]
4. Convenient high-resolution isoelectric focusing (IEF) method for the separation of alpha1-proteinase inhibitor (A1PI) isoforms in A1PI concentrates.
Weber A; Engelmaier A; Owen MC; Schwarz HP; Turecek PL
J Pharm Biomed Anal; 2007 Sep; 45(1):107-111. PubMed ID: 17629652
[TBL] [Abstract][Full Text] [Related]
5. New process for purifying high purity α1-antitrypsin from Cohn Fraction IV by chromatography: A promising method for the better utilization of plasma.
Huangfu C; Zhang J; Ma Y; Jia J; Lv M; Zhao X; Zhang J
J Chromatogr B Analyt Technol Biomed Life Sci; 2017 Mar; 1046():156-164. PubMed ID: 28183045
[TBL] [Abstract][Full Text] [Related]
6. Preparation and properties of alpha 1-proteinase inhibitor concentrate from human plasma.
Coan MH; Brockway WJ; Eguizabal H; Krieg T; Fournel M
Vox Sang; 1985; 48(6):333-42. PubMed ID: 3874474
[TBL] [Abstract][Full Text] [Related]
7. Ethanol dependence of alpha 1-antitrypsin C-terminal Lys truncation mediated by basic carboxypeptidases.
Matthiessen HP; Willemse J; Weber A; Turecek PL; Deiteren K; Hendriks D; Ehrlich HJ; Schwarz HP
Transfusion; 2008 Feb; 48(2):314-20. PubMed ID: 18028276
[TBL] [Abstract][Full Text] [Related]
8. Non enzymatic glycosylation of alpha-1-proteinase inhibitor of human plasma.
Phadke M; Billimoria FR; Ninjoor V
J Postgrad Med; 1998; 44(2):29-34. PubMed ID: 10703566
[TBL] [Abstract][Full Text] [Related]
9. Chromatographic purification of human alpha 1 proteinase inhibitor from dissolved Cohn fraction IV-1 paste.
Chen SX; Hammond DJ; Klos AM; Wood WD; Wydick JE; Lebing WR
J Chromatogr A; 1998 Mar; 800(2):207-18. PubMed ID: 9561763
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of assays for detecting alpha-1-protease inhibitor during purification from rat serum.
McGilligan K; Thomas DW
Anal Biochem; 1991 Mar; 193(2):260-5. PubMed ID: 1872472
[TBL] [Abstract][Full Text] [Related]
11. New process for the manufacture of alpha-1 antitrypsin.
Kumpalume P; Podmore A; LePage C; Dalton J
J Chromatogr A; 2007 Apr; 1148(1):31-7. PubMed ID: 17350640
[TBL] [Abstract][Full Text] [Related]
12. Albumin contamination of a purified human alpha 1-antitrypsin preparation does not affect either structural conformation or the electrophoretic mobility of the inhibitor.
Finotti P; Pagetta A
Clin Chim Acta; 1997 Aug; 264(2):133-48. PubMed ID: 9293373
[TBL] [Abstract][Full Text] [Related]
13. Trypsin and elastase inhibitors from bitter gourd (Momordica charantia LINN.) seeds: purification, amino acid sequences, and inhibitory activities of four new inhibitors.
Hamato N; Koshiba T; Pham TN; Tatsumi Y; Nakamura D; Takano R; Hayashi K; Hong YM; Hara S
J Biochem; 1995 Feb; 117(2):432-7. PubMed ID: 7608135
[TBL] [Abstract][Full Text] [Related]
14. A simple one-step purification of human alpha 1-proteinase inhibitor by immunoadsorbent column chromatography.
Sugiura M; Hayakawa S; Adachi T; Ito Y; Hirano K; Sawaki S
J Biochem Biophys Methods; 1981 Dec; 5(5):243-9. PubMed ID: 7037919
[TBL] [Abstract][Full Text] [Related]
15. Isolation and characterization of rabbit plasma alpha-1-antiproteinase E.
Saito A; Sinohara H
Biol Chem; 1998 Nov; 379(11):1367-70. PubMed ID: 9865611
[TBL] [Abstract][Full Text] [Related]
16. Pulmonary deposition and clearance of aerosolized alpha-1-proteinase inhibitor administered to dogs and to sheep.
Smith RM; Traber LD; Traber DL; Spragg RG
J Clin Invest; 1989 Oct; 84(4):1145-54. PubMed ID: 2794051
[TBL] [Abstract][Full Text] [Related]
17. Biochemical and biological properties of an alpha 1-antitrypsin concentrate.
Burnouf T; Constans J; Clerc A; Descamps J; Martinache L; Goudemand M
Vox Sang; 1987; 52(4):291-7. PubMed ID: 3498260
[TBL] [Abstract][Full Text] [Related]
18. Isolation and characterization of alpha 1-protease inhibitor from canine plasma.
Melgarejo T; Williams DA; Griffith G
Am J Vet Res; 1996 Mar; 57(3):258-63. PubMed ID: 8669751
[TBL] [Abstract][Full Text] [Related]
19. Large-scale purification of high purity α1-antitrypsin from Cohn Fraction IV with virus inactivation by solvent/detergent and dry-heat treatment.
Huangfu C; Zhang J; Ma Y; Jia J; Li J; Lv M; Ma X; Zhao X; Zhang J
Biotechnol Appl Biochem; 2018 May; 65(3):446-454. PubMed ID: 29072333
[TBL] [Abstract][Full Text] [Related]
20. Inactivation of alpha-1-proteinase inhibitor by neutrophil metalloproteinases. Crucial role of the myeloperoxidase system and effects of the anti-inflammatory drug nimesulide.
Ottonello L; Dapino P; Dallegri F
Respiration; 1993; 60(1):32-7. PubMed ID: 8385794
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
